ES2421504T3 - Derivados de dihidrobenzoxatiazepinas, procedimiento para su preparación y composiciones farmacéuticas que los contienen, así como su utilización como moduladores de los receptores ampa - Google Patents
Derivados de dihidrobenzoxatiazepinas, procedimiento para su preparación y composiciones farmacéuticas que los contienen, así como su utilización como moduladores de los receptores ampaInfo
- Publication number
- ES2421504T3 ES2421504T3 ES11290413T ES11290413T ES2421504T3 ES 2421504 T3 ES2421504 T3 ES 2421504T3 ES 11290413 T ES11290413 T ES 11290413T ES 11290413 T ES11290413 T ES 11290413T ES 2421504 T3 ES2421504 T3 ES 2421504T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- linear
- branched
- well
- dihydrobenzoxathiazepine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000003678 AMPA Receptors Human genes 0.000 title 1
- 108090000078 AMPA Receptors Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000006684 polyhaloalkyl group Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Compuestos de fórmula (I): **Fórmula** donde R1 representa un átomo de hidrógeno, un grupo ciano, un grupo alcoxicarbonilo(C 1-C6) lineal o ramificado, un grupo alquil(C1-C6)-sulfonilaminoalquilo(C1-C6) lineal o ramificado, un grupo N-hidroxicarboximidamida o un grupo heterocíclico, sus enantiómeros y sus diastereoisómeros, así como sus sales de adición a un ácido o una base farmacéuticamente aceptables, entendiéndose por el concepto "grupo heterocíclico" un grupo aromático monocíclico de 5 miembros que contiene de uno a cuatro heteroátomos, idénticos o diferentes, seleccionados entre nitrógeno, oxígeno y azufre, pudiendo dicho grupo heterocíclico estar sustituido en caso dado con uno o más sustituyentes, iguales o diferentes, seleccionados entre alquilo(C1-C6) lineal o ramificado o polihaloalquilo(C1-C6) lineal o ramificado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1003683A FR2964969B1 (fr) | 2010-09-16 | 2010-09-16 | Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2421504T3 true ES2421504T3 (es) | 2013-09-03 |
Family
ID=43067253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11290413T Active ES2421504T3 (es) | 2010-09-16 | 2011-09-15 | Derivados de dihidrobenzoxatiazepinas, procedimiento para su preparación y composiciones farmacéuticas que los contienen, así como su utilización como moduladores de los receptores ampa |
Country Status (41)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111518058B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种噁噻嗪类化合物及其用途 |
| CN111559990B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种小分子噁噻嗪类衍生物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137720A0 (en) * | 1998-02-18 | 2001-10-31 | Neurosearch As | Compounds and their use as positive ampa receptor modulators |
| TWI232863B (en) * | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
| MXPA03011562A (es) * | 2001-06-14 | 2004-03-18 | Akzo Nobel Nv | Derivados de (pirido/tieno)-(f)-oxazepin-5-ona como moduladores positivos del receptor ampa. |
| FR2856064B1 (fr) * | 2003-06-13 | 2005-08-19 | Servier Lab | Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
-
2010
- 2010-09-16 FR FR1003683A patent/FR2964969B1/fr not_active Expired - Fee Related
-
2011
- 2011-08-24 UY UY0001033574A patent/UY33574A/es unknown
- 2011-08-25 AU AU2011213898A patent/AU2011213898A1/en not_active Abandoned
- 2011-08-30 ZA ZA2011/06353A patent/ZA201106353B/en unknown
- 2011-09-07 TW TW100132314A patent/TWI421080B/zh not_active IP Right Cessation
- 2011-09-07 CA CA2752131A patent/CA2752131C/fr not_active Expired - Fee Related
- 2011-09-14 AR ARP110103332A patent/AR082973A1/es unknown
- 2011-09-14 SA SA111320755A patent/SA111320755B1/ar unknown
- 2011-09-15 MX MX2013002892A patent/MX2013002892A/es active IP Right Grant
- 2011-09-15 EP EP11290413.1A patent/EP2431360B1/fr active Active
- 2011-09-15 AP AP2013006793A patent/AP2013006793A0/xx unknown
- 2011-09-15 JP JP2013528735A patent/JP2013537216A/ja active Pending
- 2011-09-15 GE GEAP201113048A patent/GEP20156247B/en unknown
- 2011-09-15 ES ES11290413T patent/ES2421504T3/es active Active
- 2011-09-15 DK DK11290413.1T patent/DK2431360T3/da active
- 2011-09-15 SG SG2013015904A patent/SG188380A1/en unknown
- 2011-09-15 RS RS20130274A patent/RS52835B/sr unknown
- 2011-09-15 US US13/200,045 patent/US8569285B2/en not_active Expired - Fee Related
- 2011-09-15 UA UAA201304534A patent/UA105320C2/ru unknown
- 2011-09-15 KR KR1020137009580A patent/KR20130054438A/ko not_active Ceased
- 2011-09-15 PE PE2013000377A patent/PE20131342A1/es not_active Application Discontinuation
- 2011-09-15 PT PT112904131T patent/PT2431360E/pt unknown
- 2011-09-15 PH PH1/2013/500423A patent/PH12013500423A1/en unknown
- 2011-09-15 BR BR112013005967A patent/BR112013005967A2/pt not_active Application Discontinuation
- 2011-09-15 MA MA35744A patent/MA34529B1/fr unknown
- 2011-09-15 ME MEP-2013-82A patent/ME01524B/me unknown
- 2011-09-15 CN CN2011800437978A patent/CN103153973A/zh active Pending
- 2011-09-15 WO PCT/FR2011/000502 patent/WO2012035216A1/fr not_active Ceased
- 2011-09-15 PL PL11290413T patent/PL2431360T3/pl unknown
- 2011-09-15 SI SI201130030T patent/SI2431360T1/sl unknown
- 2011-09-15 EA EA201300340A patent/EA201300340A1/ru unknown
-
2013
- 2013-03-08 CL CL2013000655A patent/CL2013000655A1/es unknown
- 2013-03-11 CR CR20130105A patent/CR20130105A/es unknown
- 2013-03-12 CO CO13049160A patent/CO6680709A2/es not_active Application Discontinuation
- 2013-03-14 IL IL225209A patent/IL225209A0/en unknown
- 2013-03-14 NI NI201300028A patent/NI201300028A/es unknown
- 2013-03-14 CU CU2013000037A patent/CU20130037A7/es unknown
- 2013-03-14 GT GT201300067A patent/GT201300067A/es unknown
- 2013-03-15 EC ECSP13012489 patent/ECSP13012489A/es unknown
- 2013-06-07 HR HRP20130505AT patent/HRP20130505T1/hr unknown
- 2013-07-03 CY CY20131100553T patent/CY1114110T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR061739A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR089774A1 (es) | Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR088226A1 (es) | Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas | |
| ECSP11010830A (es) | Derivados de heteroarilo como inhibidores de dgat1 | |
| AR072373A1 (es) | Tiadiazoliloxifenilamidinas, el uso de las mismas como fungicidas en composiciones y metodos de uso, proceso para su preparacion e intermediarios de sus sintesis. | |
| AR068538A1 (es) | Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido | |
| CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| AR075892A1 (es) | Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| AR083903A1 (es) | Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos | |
| ECSP088805A (es) | 2-(piridin-2-il)-pirimidinas como fungicidas | |
| CU20100157A7 (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| AR091687A1 (es) | Formas solidas de inhibidores de fosfodiesterasa tipo 5 | |
| ES2606839T3 (es) | Tetraaza-ciclopenta[a]indenilo y su uso como moduladores alostéricos positivos | |
| AR072486A1 (es) | Derivados de benzotiadiazinas cicloalquiladas su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| ES2421504T3 (es) | Derivados de dihidrobenzoxatiazepinas, procedimiento para su preparación y composiciones farmacéuticas que los contienen, así como su utilización como moduladores de los receptores ampa | |
| AR063328A1 (es) | Derivados indolicos su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR054747A1 (es) | Compuestos de indanil-piperazina un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR061740A1 (es) | Nuevos derivados naftalenicos, su procedimiento de praparacion y las composiciones farmaceuticas que los contienen | |
| MX2009004007A (es) | Nuevos derivados de indol, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| AR061741A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CU20120041A7 (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| NI201000111A (es) | Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| AR074395A1 (es) | Derivados de indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CO6240165A1 (es) | Nuevos compuestos piperidinicos su procedimiento piperidinicos su procedimeinto de preparacion y las composiciones farmaceuticas que los contienen |